A pilot study involving minimal ovarian stimulation for in vitro fertilization: Extending the 'follicle-stimulating hormone window' combined with the gonadotropin-releasing hormone antagonist cetrorelix

Fertility and Sterility

Volumn 73, Issue 5, 2000, Pages 1051-1054

  De Jong, Diederick ^a   Macklon, Nicholas S ^a   Fauser, Bart C J M ^a  

^a ERASMUS UNIVERSITY ROTTERDAM   (Netherlands)

Author keywords

GnRH antagonist; IVF; Minimal ovarian stimulation; Recombinant FSH

Indexed keywords

CETRORELIX; RECOMBINANT FOLLITROPIN;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; FERTILIZATION IN VITRO; FOLLICULAR PHASE; HUMAN; MENSTRUAL CYCLE; OUTCOMES RESEARCH; OVARY FOLLICLE; OVARY FOLLICLE DEVELOPMENT; OVULATION INDUCTION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TREATMENT INDICATION;

ADULT; DRUG THERAPY, COMBINATION; ESTRADIOL; FEMALE; FERTILIZATION IN VITRO; FOLLICLE STIMULATING HORMONE; FOLLICULAR PHASE; GONADOTROPIN-RELEASING HORMONE; HORMONE ANTAGONISTS; HUMANS; LUTEAL PHASE; LUTEINIZING HORMONE; OVULATION INDUCTION; PILOT PROJECTS; PREGNANCY RATE; PROGESTERONE; RECOMBINANT PROTEINS;

EID: 0033994130     PISSN: 00150282     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0015-0282(00)00414-3     Document Type: Article

References (4)

1. van Santbrink E.J., Hop W.C., van Dessel T.J., de Jong F.H., Fauser B.C. Decremental follicle-stimulating hormone and dominant follicle development during the normal menstrual cycle. Fertil Steril. 64:1995;37-43.
2. Fauser B.C., Van Heusden A.M. Manipulation of human ovarian function physiological concepts and clinical consequences . Endocr Rev. 18:1997;71-106.
3. Schipper I., Hop W.C., Fauser B.C. The follicle-stimulating hormone (FSH) threshold/window concept examined by different interventions with exogenous FSH during the follicular phase of the normal menstrual cycle duration, rather than magnitude, of FSH increase affects follicle development . J Clin Endocrinol Metab. 83:1998;1292-1298.
4. Ditkoff E.C., Cassidenti D.L., Paulson R.J., Sauer M.V., Paul W.L., Rivier J., et al. The gonadotropin-releasing hormone antagonist (Nal-Glu) acutely blocks the luteinizing hormone surge but allows for resumption of folliculogenesis in normal women. Am J Obstet Gynecol. 165:1991;1811-1817.